Mustang Bio (MBIO) was granted orphan designation from the FDA for a treatment of malignant glioma, according to a post to the agency’s website.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBIO: